LANI STEARNS: Open Payments
NPI 1821745852 · MARION, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,522 in 116 payments from 32 companies in 2025. Trend: 2023 $2,595 · 2024 $4,042 · 2025 $2,522
Food & beverage: $2,402Long term medical supply or device loan: $100Education: $20
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $373 |
| E.R. Squibb & Sons, L.L.C. | 13 | $251 |
| Celgene Corporation | 2 | $164 |
| Eisai Inc. | 5 | $146 |
| AstraZeneca Pharmaceuticals LP | 7 | $144 |
| Merck Sharp & Dohme LLC | 7 | $135 |
| Daiichi Sankyo Inc. | 5 | $126 |
| ABBVIE INC. | 7 | $108 |
| PFIZER INC. | 6 | $108 |
| Janssen Biotech, Inc. | 4 | $92 |
Products named: OPDIVO, KISQALI, Lenvima, REBLOZYL, KEYTRUDA, Epkinly, VERZENIO, Trodelvy.
Industry payments across IN — which companies pay providers there.
